Global mRNA Vaccines Market Growth (Status and Outlook) 2020-2025

  • receipt Report ID : 59779
  • calendar_today Published On: May, 2020
  • file_copy Pages: 117
  • list Information & Communication Technology
Buy @ $3660

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of mRNA Vaccines will have significant change from previous year. By the most conservative estimates of global mRNA Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the mRNA Vaccines market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the mRNA Vaccines, covering the supply chain analysis, impact assessment to the mRNA Vaccines market size growth rate in several scenarios, and the measures to be undertaken by mRNA Vaccines companies in response to the COVID-19 epidemic.

Segmentation by product type:

Being Developed

Preclinical

Clinical I

Clinical II

Segmentation by Application:

COVID-19

Cancer

Infectious Disease Treatment MRNA Vaccine

Infection Prevention MRNA Vaccine

This report also splits the market by region:

Americas

United States

Canada

Mexico

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/players in the market. The key players covered in this report:

MODERNA

Pfizer

Fosun Pharmaceutical

CureVac

Zydus Cadila

Stemirna

...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global mRNA Vaccines market size by key regions/countries, type and application.

To understand the structure of mRNA Vaccines market by identifying its various subsegments.

Focuses on the key global mRNA Vaccines players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the mRNA Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of mRNA Vaccines submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

1.8 What is the Impact of Covid-19 Outbreak On the mRNA Vaccines?

1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.

1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.

1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global mRNA Vaccines Market Size in 2020, by Scenario

1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary

2.1 World Market Overview

2.1.1 Global mRNA Vaccines Market Size 2021-2025

2.1.2 mRNA Vaccines Market Size CAGR by Region

2.2 mRNA Vaccines Segment by Type

2.2.1 Being Developed

2.2.2 Preclinical

2.2.3 Clinical I

2.2.4 Clinical II

2.3 mRNA Vaccines Market Size by Type

2.3.1 Global mRNA Vaccines Market Size Market Share by Type (2021-2025)

2.3.2 Global mRNA Vaccines Market Size Growth Rate by Type (2021-2025)

2.4 mRNA Vaccines Segment by Application

2.4.1 COVID-19

2.4.2 Cancer

2.4.3 Infectious Disease Treatment MRNA Vaccine

2.4.4 Infection Prevention MRNA Vaccine

2.5 mRNA Vaccines Market Size by Application

2.5.1 Global mRNA Vaccines Market Size Market Share by Application (2021-2025)

2.5.2 Global mRNA Vaccines Market Size Growth Rate by Application (2021-2025)

3 mRNA Vaccines Key Players

3.1 Date of Key Players Enter into mRNA Vaccines

3.2 Key Players mRNA Vaccines Product Offered

3.3 Key Players mRNA Vaccines Funding/Investment Analysis

3.4 Funding/Investment

3.4.1 Funding/Investment by Regions

3.4.2 Funding/Investment by End-Industry

3.5 Key Players mRNA Vaccines Valuation & Market Capitalization

3.6 Key Players Mergers & Acquisitions, Expansion Plans

3.7 Market Ranking

3.8 New Product/Technology Launches

3.9 Partnerships, Agreements, and Collaborations

3.10 Mergers and Acquisitions

4 mRNA Vaccines by Regions

4.1 mRNA Vaccines Market Size by Regions (2015-2020)

4.2 Americas mRNA Vaccines Market Size Growth (2015-2020)

4.3 APAC mRNA Vaccines Market Size Growth (2015-2020)

4.4 Europe mRNA Vaccines Market Size Growth (2015-2020)

5 Americas

5.1 Americas mRNA Vaccines Market Size by Countries (2021-2025)

5.2 Americas mRNA Vaccines Market Size by Type (2021-2025)

5.3 Americas mRNA Vaccines Market Size by Application (2021-2025)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC mRNA Vaccines Market Size by Regions

6.2 APAC mRNA Vaccines Market Size by Type (2021-2025)

6.3 APAC mRNA Vaccines Market Size by Application (2021-2025)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe mRNA Vaccines by Countries (2021-2025)

7.2 Europe mRNA Vaccines Market Size by Type (2021-2025)

7.3 Europe mRNA Vaccines Market Size by Application (2021-2025)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Market Drivers, Challenges and Trends

8.1 Market Drivers and Impact

8.1.1 Growing Demand from Key Regions

8.1.2 Growing Demand from Key Applications and Potential Industries

8.2 Market Challenges and Impact

8.3 Market Trends

8.4 Market Ecosystem and Roles

9 Key Investors in mRNA Vaccines

9.1 Company A

9.1.1 Company A Company Details

9.1.2 Company Description

9.1.3 Companies Invested by Company A

9.1.4 Company A Key Development and Market Layout

9.2 Company B

9.2.1 Company B Company Details

9.2.2 Company Description

9.2.3 Companies Invested by Company B

9.2.4 Company B Key Development and Market Layout

9.3 Company C

9.3.1 Company C Company Details

9.3.2 Company Description

9.3.3 Companies Invested by Company C

9.3.4 Company C Key Development and Market Layout

9.4 Company D

9.5 ……

10 Key Players Analysis

10.1 MODERNA

10.1.1 MODERNA Company Information

10.1.2 mRNA Vaccines Product Offered

10.1.3 MODERNA mRNA Vaccines Market Size (2020 VS 2025)

10.1.4 Main Business Overview

10.1.5 MODERNA Latest Developments

10.2 Pfizer

10.2.1 Pfizer Company Information

10.2.2 mRNA Vaccines Product Offered

10.2.3 Pfizer mRNA Vaccines Market Size (2020 VS 2025)

10.2.4 Main Business Overview

10.2.5 Pfizer Latest Developments

10.3 Fosun Pharmaceutical

10.3.1 Fosun Pharmaceutical Company Information

10.3.2 mRNA Vaccines Product Offered

10.3.3 Fosun Pharmaceutical mRNA Vaccines Market Size (2020 VS 2025)

10.3.4 Main Business Overview

10.3.5 Fosun Pharmaceutical Latest Developments

10.4 CureVac

10.4.1 CureVac Company Information

10.4.2 mRNA Vaccines Product Offered

10.4.3 CureVac mRNA Vaccines Market Size (2020 VS 2025)

10.4.4 Main Business Overview

10.4.5 CureVac Latest Developments

10.5 Zydus Cadila

10.5.1 Zydus Cadila Company Information

10.5.2 mRNA Vaccines Product Offered

10.5.3 Zydus Cadila mRNA Vaccines Market Size (2020 VS 2025)

10.5.4 Main Business Overview

10.5.5 Zydus Cadila Latest Developments

10.6 Stemirna

10.6.1 Stemirna Company Information

10.6.2 mRNA Vaccines Product Offered

10.6.3 Stemirna mRNA Vaccines Market Size (2020 VS 2025)

10.6.4 Main Business Overview

10.6.5 Stemirna Latest Developments

...

11 Research Findings and Conclusion

List of Tables

Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global mRNA Vaccines Market Size in 2020, by Scenario

Table 2. COVID-19: Measures to be Undertaken by mRNA Vaccines Companies

Table 3. Research Methodology

Table 4. Data Source

Table 5. mRNA Vaccines Market Size CAGR by Region (2021-2025) ($ Millions)

Table 6. Major Players of Being Developed

Table 7. Major Players of Preclinical

Table 8. Major Players of Clinical I

Table 9. Major Players of Clinical II

Table 10. Global Market Size by Type (2021-2025) ($ Millions)

Table 11. Global mRNA Vaccines Market Size Market Share by Type (2021-2025)

Table 12. Global mRNA Vaccines Market Size by Application (2021-2025) ($ Millions)

Table 13. Global mRNA Vaccines Market Size Market Share by Application (2021-2025)

Table 14. Date of Global Key Players Enter into mRNA Vaccines Market

Table 15. Global Key Players mRNA Vaccines Product Offered

Table 16. Key Players mRNA Vaccines Funding/Investment ($ Millions)

Table 17. Funding/Investment by Regions

Table 18. Funding/Investment by End Industry

Table 19. Key Players mRNA Vaccines Valuation & Market Capitalization ($ Millions)

Table 20. Key Players Mergers & Acquisitions, Expansion Plans

Table 21. mRNA Vaccines New Product/Technology Launches

Table 22. mRNA Vaccines Industry Partnerships, Agreements, and Collaborations

Table 23. mRNA Vaccines Industry Mergers and Acquisitions

Table 24. Global mRNA Vaccines Market Size by Regions 2021-2025 ($ Millions)

Table 25. Global mRNA Vaccines Market Size Market Share by Regions 2021-2025

Table 26. Americas mRNA Vaccines Market Size by Countries (2021-2025) ($ Millions)

Table 27. Americas mRNA Vaccines Market Size Market Share by Countries (2021-2025)

Table 28. Americas mRNA Vaccines Market Size by Type (2021-2025) ($ Millions)

Table 29. Americas mRNA Vaccines Market Size Market Share by Type (2021-2025)

Table 30. Americas mRNA Vaccines Market Size by Application (2021-2025) ($ Millions)

Table 31. Americas mRNA Vaccines Market Size Market Share by Application (2021-2025)

Table 32. APAC mRNA Vaccines Market Size by Regions (2021-2025) ($ Millions)

Table 33. APAC mRNA Vaccines Market Size Market Share by Regions (2021-2025)

Table 34. APAC mRNA Vaccines Market Size by Type (2021-2025) ($ Millions)

Table 35. APAC mRNA Vaccines Market Size Market Share by Type (2021-2025)

Table 36. APAC mRNA Vaccines Market Size by Application (2021-2025) ($ Millions)

Table 37. APAC mRNA Vaccines Market Size Market Share by Application (2021-2025)

Table 38. Europe mRNA Vaccines Market Size by Countries (2021-2025) ($ Millions)

Table 39. Europe mRNA Vaccines Market Size Market Share by Countries (2021-2025)

Table 40. Europe mRNA Vaccines Market Size by Type (2021-2025) ($ Millions)

Table 41. Europe mRNA Vaccines Market Size Market Share by Type (2021-2025)

Table 42. Europe mRNA Vaccines Market Size by Application (2021-2025) ($ Millions)

Table 43. Europe mRNA Vaccines Market Size Market Share by Application (2021-2025)

Table 44. Key and Potential Regions of mRNA Vaccines

Table 45. Key Application and Potential Industries of mRNA Vaccines

Table 46. Key Challenges of mRNA Vaccines

Table 47. Key Trends of mRNA Vaccines

Table 48. Company A Company Details

Table 49. Companies Invested by Company A

Table 50. Company A Key Development and Market Layout

Table 51. Company B Company Details

Table 52. Companies Invested by Company B

Table 53. Company B Key Development and Market Layout

Table 54. Company C Company Details

Table 55. Companies Invested by Company C

Table 56. Company C Key Development and Market Layout

Table 57. Company C Company Details

Table 58. Companies Invested by Company C

Table 59. Company C Key Development and Market Layout

Table 60. MODERNA Basic Information, Head Office, Major Market Areas and Its Competitors

Table 61. MODERNA mRNA Vaccines Market Size (2020 VS 2025)

Table 62. Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors

Table 63. Pfizer mRNA Vaccines Market Size (2020 VS 2025)

Table 64. Fosun Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors

Table 65. Fosun Pharmaceutical mRNA Vaccines Market Size (2020 VS 2025)

Table 66. CureVac Basic Information, Head Office, Major Market Areas and Its Competitors

Table 67. CureVac mRNA Vaccines Market Size (2020 VS 2025)

Table 68. Zydus Cadila Basic Information, Head Office, Major Market Areas and Its Competitors

Table 69. Zydus Cadila mRNA Vaccines Market Size (2020 VS 2025)

Table 70. Stemirna Basic Information, Head Office, Major Market Areas and Its Competitors

Table 71. Stemirna mRNA Vaccines Market Size (2020 VS 2025)

List of Figures

Figure 1. Picture of mRNA Vaccines

Figure 2. mRNA Vaccines Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global mRNA Vaccines Market Size Growth Rate 2021-2025 ($ Millions)

Figure 5. mRNA Vaccines Market Size by Region (2020 & 2025) ($ millions)

Figure 6. Global mRNA Vaccines Market Size Market Share by Type (2021-2025)

Figure 7. Global Being Developed Market Size Growth Rate

Figure 8. Global Preclinical Market Size Growth Rate

Figure 9. Global Clinical I Market Size Growth Rate

Figure 10. Global Clinical II Market Size Growth Rate

Figure 11. mRNA Vaccines Consumed in COVID-19

Figure 12. Global mRNA Vaccines Market: COVID-19 (2021-2025) ($ Millions)

Figure 13. Global COVID-19 YoY Growth ($ Millions)

Figure 14. mRNA Vaccines Consumed in Cancer

Figure 15. Global mRNA Vaccines Market: Cancer (2021-2025) ($ Millions)

Figure 16. Global Cancer YoY Growth ($ Millions)

Figure 17. mRNA Vaccines Consumed in Infectious Disease Treatment MRNA Vaccine

Figure 18. Global mRNA Vaccines Market: Infectious Disease Treatment MRNA Vaccine (2021-2025) ($ Millions)

Figure 19. Global Infectious Disease Treatment MRNA Vaccine YoY Growth ($ Millions)

Figure 20. mRNA Vaccines Consumed in Infection Prevention MRNA Vaccine

Figure 21. Global mRNA Vaccines Market: Infection Prevention MRNA Vaccine (2021-2025) ($ Millions)

Figure 22. Global Infection Prevention MRNA Vaccine YoY Growth ($ Millions)

Figure 23. Global mRNA Vaccines Market Size Market Share by Application (2021-2025)

Figure 24. Global mRNA Vaccines Market Size in COVID-19 Growth Rate

Figure 25. Global mRNA Vaccines Market Size in Cancer Growth Rate

Figure 26. Global mRNA Vaccines Market Size in Infectious Disease Treatment MRNA Vaccine Growth Rate

Figure 27. Global mRNA Vaccines Market Size in Infection Prevention MRNA Vaccine Growth Rate

Figure 28. Funding/Investment

Figure 29. Global mRNA Vaccines Market Size Market Share by Regions 2021-2025

Figure 30. Americas mRNA Vaccines Market Size 2021-2025 ($ Millions)

Figure 31. APAC mRNA Vaccines Market Size 2021-2025 ($ Millions)

Figure 32. Europe mRNA Vaccines Market Size 2021-2025 ($ Millions)

Figure 33. Americas mRNA Vaccines Market Size Market Share by Countries in 2020

Figure 34. Americas mRNA Vaccines Market Size Market Share by Type in 2020

Figure 35. Americas mRNA Vaccines Market Size Market Share by Application in 2020

Figure 36. United States mRNA Vaccines Market Size Growth 2021-2025 ($ Millions)

Figure 37. Canada mRNA Vaccines Market Size Growth 2021-2025 ($ Millions)

Figure 38. Mexico mRNA Vaccines Market Size Growth 2021-2025 ($ Millions)

Figure 39. APAC mRNA Vaccines Market Size Market Share by Regions in 2020

Figure 40. APAC mRNA Vaccines Market Size Market Share by Type in 2020

Figure 41. APAC mRNA Vaccines Market Size Market Share by Application in 2020

Figure 42. China mRNA Vaccines Market Size Growth 2021-2025 ($ Millions)

Figure 43. Japan mRNA Vaccines Market Size Growth 2021-2025 ($ Millions)

Figure 44. Korea mRNA Vaccines Market Size Growth 2021-2025 ($ Millions)

Figure 45. Southeast Asia mRNA Vaccines Market Size Growth 2021-2025 ($ Millions)

Figure 46. India mRNA Vaccines Market Size Growth 2021-2025 ($ Millions)

Figure 47. Australia mRNA Vaccines Market Size Growth 2021-2025 ($ Millions)

Figure 48. Europe mRNA Vaccines Market Size Market Share by Countries in 2020

Figure 49. Europe mRNA Vaccines Market Size Market Share by Type in 2020

Figure 50. Europe mRNA Vaccines Market Size Market Share by Application in 2020

Figure 51. Germany mRNA Vaccines Market Size Growth 2021-2025 ($ Millions)

Figure 52. France mRNA Vaccines Market Size Growth 2021-2025 ($ Millions)

Figure 53. UK mRNA Vaccines Market Size Growth 2021-2025 ($ Millions)

Figure 54. Italy mRNA Vaccines Market Size Growth 2021-2025 ($ Millions)

Figure 55. Russia mRNA Vaccines Market Size Growth 2021-2025 ($ Millions)